Dimensional Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$265M Sell
596,227
-9,652
-2% -$4.3M 0.06% 355
2025
Q1
$294M Sell
605,879
-21,638
-3% -$10.5M 0.07% 274
2024
Q4
$253M Sell
627,517
-20,291
-3% -$8.17M 0.06% 359
2024
Q3
$301M Sell
647,808
-15,149
-2% -$7.05M 0.07% 285
2024
Q2
$311M Buy
662,957
+75,045
+13% +$35.2M 0.08% 223
2024
Q1
$246M Buy
587,912
+2,696
+0.5% +$1.13M 0.07% 325
2023
Q4
$238M Sell
585,216
-7,179
-1% -$2.92M 0.07% 306
2023
Q3
$206M Sell
592,395
-18,304
-3% -$6.37M 0.07% 312
2023
Q2
$215M Sell
610,699
-10,116
-2% -$3.56M 0.07% 306
2023
Q1
$196M Sell
620,815
-159,687
-20% -$50.3M 0.07% 326
2022
Q4
$225K Sell
780,502
-83,805
-10% -$24.2K 0.07% 273
2022
Q3
$250M Sell
864,307
-17,338
-2% -$5.02M 0.1% 200
2022
Q2
$248M Sell
881,645
-71,529
-8% -$20.2M 0.09% 213
2022
Q1
$249M Buy
953,174
+19,141
+2% +$4.99M 0.08% 279
2021
Q4
$205M Buy
934,033
+229,487
+33% +$50.4M 0.06% 361
2021
Q3
$128M Buy
704,546
+185,523
+36% +$33.7M 0.04% 635
2021
Q2
$105M Buy
519,023
+49,412
+11% +$9.96M 0.03% 814
2021
Q1
$101M Buy
469,611
+15,062
+3% +$3.24M 0.03% 823
2020
Q4
$107M Buy
454,549
+18,974
+4% +$4.48M 0.04% 685
2020
Q3
$119M Buy
435,575
+3,625
+0.8% +$986K 0.05% 456
2020
Q2
$125M Buy
431,950
+35,100
+9% +$10.2M 0.06% 400
2020
Q1
$94.4M Buy
396,850
+22,425
+6% +$5.33M 0.05% 462
2019
Q4
$82M Buy
374,425
+1,852
+0.5% +$405K 0.03% 904
2019
Q3
$63.1M Buy
372,573
+1,056
+0.3% +$179K 0.02% 1150
2019
Q2
$68.1M Buy
371,517
+6,005
+2% +$1.1M 0.03% 1081
2019
Q1
$67.2M Buy
365,512
+40,427
+12% +$7.44M 0.03% 1066
2018
Q4
$53.9M Buy
325,085
+11,848
+4% +$1.96M 0.02% 1151
2018
Q3
$60.4M Sell
313,237
-8,109
-3% -$1.56M 0.02% 1242
2018
Q2
$54.6M Buy
321,346
+200
+0.1% +$34K 0.02% 1321
2018
Q1
$52.3M Buy
321,146
+8,640
+3% +$1.41M 0.02% 1292
2017
Q4
$46.8M Buy
312,506
+15,625
+5% +$2.34M 0.02% 1420
2017
Q3
$45.1M Buy
296,881
+14,066
+5% +$2.14M 0.02% 1405
2017
Q2
$36.4M Buy
282,815
+9,882
+4% +$1.27M 0.02% 1572
2017
Q1
$29.8M Buy
272,933
+5,496
+2% +$601K 0.01% 1704
2016
Q4
$19.7M Buy
267,437
+8,524
+3% +$628K 0.01% 1990
2016
Q3
$22.6M Buy
258,913
+9,896
+4% +$863K 0.01% 1823
2016
Q2
$21.4M Buy
249,017
+810
+0.3% +$69.7K 0.01% 1776
2016
Q1
$19.7M Buy
248,207
+8,583
+4% +$682K 0.01% 1823
2015
Q4
$30.2M Buy
239,624
+14,019
+6% +$1.76M 0.02% 1388
2015
Q3
$23.5M Sell
225,605
-113
-0.1% -$11.8K 0.02% 1577
2015
Q2
$27.9M Sell
225,718
-5,656
-2% -$698K 0.02% 1503
2015
Q1
$27.3M Buy
231,374
+1,117
+0.5% +$132K 0.02% 1474
2014
Q4
$27.4M Buy
230,257
+2,319
+1% +$276K 0.02% 1405
2014
Q3
$25.6M Buy
227,938
+2,163
+1% +$243K 0.02% 1356
2014
Q2
$21.4M Sell
225,775
-523
-0.2% -$49.5K 0.01% 1596
2014
Q1
$16M Buy
226,298
+2,655
+1% +$188K 0.01% 1795
2013
Q4
$16.6M Buy
223,643
+16,274
+8% +$1.21M 0.01% 1724
2013
Q3
$15.7M Buy
207,369
+60,681
+41% +$4.6M 0.01% 1696
2013
Q2
$11.7M Buy
+146,688
New +$11.7M 0.01% 1869